Featuring commentary from Dr. Raza Bokhari, executive cochairman of the cannabis company, FSD Pharma. There has been a rapid evolution in the cannabis industry. Formerly a taboo drug, cannabis is increasingly accepted and the subject of regulatory approval. In the United States, it is legal in 33 states to use cannabis …
Read More »
Largest Hydroponic Indoor Cannabis Facility in the World FSD Pharma is a licensed producer of medicinal cannabis. We are fully developed. We have three point nine million square feet of facility that would have a capacity to produce 400 thousand kg of cannabis a year over year. We have a …
Read More »
FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) CEO Interview with Dr. Raza Bokhari. FSD Pharma is building the worlds largest licensed indoor cannabis growing facility in the world, located in Coburg, Ontario, Canada. We caught up with Dr. Bokhari as he was driving to the airport for his flight to …
Read More »
An interview with Dr Raza Bokhari, Executive Co-Chairman & Interim CEO CSE:HUGE, OTC:FSDDF, FRA:0K9 SOURCE: FSD PHARMA
Read More »
“The #cannabinoid ecosystem is creating a tsunami of opportunities, but also presents challenges…”-Dr. Raza Bokhari The CEO of FSD Pharma, @R_Bhokari, delivered the keynote address at ArcView Investor Conference in Vancouver last week. SOURCE: FSD PHARMA
Read More »
FSD Pharma Inc. (OTCQB:FSDDF)(CSE:HUGE) Interim CEO Raza Bokhari sat down with Christine Corrado from Proactive Investors New York at the 11th Annual Biotech Showcase in San Francisco. The Canadian cannabis company, through its wholly-owned subsidiary FV Pharma Inc., holds an ACMPR license to cultivate cannabis under the Access to Cannabis …
Read More »
Dr Raza Bokhari, Executive Co-Chairman & Interim CEO CSE:HUGE, OTC:FSDDF, FRA:0K9 FSD has 25,000 square feet available for production at its Ontario facility with an additional 220,000 square feet currently in development. FSD’s R&D platform is focused on cannabinoids and their potential for widespread clinical applications. FSD has a strong …
Read More »
FSD Pharma (CSE:HUGE-OTCQB:FSDDF) Executive Co-Chairman and CEO Dr Raza Bokhari sat down with Steve Darling from Proactive Investors Vancouver to talk about FSD hitting a company milestone by receiving their cannabis sales license from Health Canada. Dr Bokhari also told Proactive about their recent acquisition of Prismic Pharmaceuticals. That company …
Read More »
Cannara Biotech Inc.(CSE: LOVE), a vertically integrated Cannabis company focused on cannabis-infused products, today announced it is entering the U.S. Hemp-CBD market, through a subsidiary, with an online e-commerce platform called shopCBD.com. The new e-commerce platform will showcase retail products from Hemp-CBD manufacturers for the U.S. consumer market. With several …
Read More »
Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists. FSD Pharma Inc. (“FSD Pharma” or the “Company”) (OTCPK:FSDDF) (HUGE:CN) (HUGE:CNX) announced the signing of a binding letter of intent (the “LOI”) to acquire Therapix Biosciences Ltd. (“Therapix Biosciences” or “Therapix”) (NASDAQ: …
Read More »Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!
Investment value finders Investment value finders